The effectiveness of bismuth breast shielding with protocol optimization in CT Thorax examination.


Journal

Journal of X-ray science and technology
ISSN: 1095-9114
Titre abrégé: J Xray Sci Technol
Pays: Netherlands
ID NLM: 9000080

Informations de publication

Date de publication:
2019
Historique:
pubmed: 26 12 2018
medline: 25 7 2020
entrez: 26 12 2018
Statut: ppublish

Résumé

Numerous techniques had been proposed to reduce radiation exposure in computed tomography (CT) including the use of radiation shielding. This study aims to evaluate efficacy of using a bismuth breast shield and optimized scanning parameter to reduce breast absorbed doses from CT thorax examination. Five protocols comprising the standard CT thorax clinical protocol (CP1) and four modified protocols (CP2 to CP5) were applied in anthropomorphic phantom scans. The phantom was configured as a female by placing a breast component on the chest. The breast component was divided into four quadrants, where 2 thermoluminescence dosimeters (TLD-100) were inserted into each quadrant to measure the absorbed dose. The bismuth shield was placed over the breast component during CP4 and CP5 scans. The pattern of absorbed doses in each breast and quadrant were approximately the same for all protocols, where the 4th quadrant > 3rd quadrant > 2nd quadrant > 1st quadrant. The mean absorbed dose value in CP3 was reduced to almost 34% of CP1's mean absorbed dose. It was reduced even lower to 15% of CP1's mean absorbed dose when the breast shield was used in CP5. This study showed that CT radiation exposure on the breast could be reduced by using a bismuth shield and low tube potential protocol without compromising the image quality.

Sections du résumé

BACKGROUND
Numerous techniques had been proposed to reduce radiation exposure in computed tomography (CT) including the use of radiation shielding.
OBJECTIVE
This study aims to evaluate efficacy of using a bismuth breast shield and optimized scanning parameter to reduce breast absorbed doses from CT thorax examination.
METHODS
Five protocols comprising the standard CT thorax clinical protocol (CP1) and four modified protocols (CP2 to CP5) were applied in anthropomorphic phantom scans. The phantom was configured as a female by placing a breast component on the chest. The breast component was divided into four quadrants, where 2 thermoluminescence dosimeters (TLD-100) were inserted into each quadrant to measure the absorbed dose. The bismuth shield was placed over the breast component during CP4 and CP5 scans.
RESULTS
The pattern of absorbed doses in each breast and quadrant were approximately the same for all protocols, where the 4th quadrant > 3rd quadrant > 2nd quadrant > 1st quadrant. The mean absorbed dose value in CP3 was reduced to almost 34% of CP1's mean absorbed dose. It was reduced even lower to 15% of CP1's mean absorbed dose when the breast shield was used in CP5.
CONCLUSION
This study showed that CT radiation exposure on the breast could be reduced by using a bismuth shield and low tube potential protocol without compromising the image quality.

Identifiants

pubmed: 30584178
pii: XST180397
doi: 10.3233/XST-180397
doi:

Substances chimiques

Bismuth U015TT5I8H

Types de publication

Evaluation Study Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

139-147

Auteurs

M K A Karim (MKA)

Department of Physics, Faculty of Science, Universiti Putra Malaysia, 43400 Serdang, Selangor, Malaysia.

N A Rahim (NA)

Department of Radiology, National Cancer Institute, Precint 7, 62250 Putrajaya, Malaysia.

K Matsubara (K)

Department of Quantum Medical Technology, Faculty of Health Sciences, Kanazawa University, Japan.

S Hashim (S)

Department of Physics, Faculty of Science, Universiti Teknologi Malaysia Johor Baru, Malaysia.

M H A Mhareb (MHA)

Department of Physics, College of Science, Imam Abdurrahman Bin Faisal University, Saudi Arabia, City Dammam, Saudi Arabia.

Y Musa (Y)

Department of Physics, Faculty of Science, Universiti Teknologi Malaysia Johor Baru, Malaysia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH